Belzutifan and other Novel Therapies in Genitourinary Oncology 2023 By Rana McKay, MD – University of California San Diego We’re gonna start with kidney cancer and go through Belzutifan, Relatlimab, SRF-388 and the others that are listed here. Then we’ll go into. And finally urothelial cancer. This is gonna  be a little bit of a … Continue reading Abemaciclib: 2023 Kidney Cancer Breakthroughs Rana McKay, MD Slides